Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001840574

SEC filings (opens in a new tab)

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Verve Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of VERV: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	157	1	163	+7
Shares	74.7M	259.6K	81.6M	+7.16M (+9.6%)
Value	$1.04B	$3.62M	$1.08B	+$46.0M (+4.4%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Verve Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to VERV in Q1 2024
Institution	Shares	Value	% of portfolio
Millennium Management LLC	614,430	$8.16M	0.01%
Trexquant Investment LP	162,763	$2.16M	0.04%
Arrowstreet Capital, Limited Partnership	67,696	$899.0K	0.00%
LPL Financial LLC	44,363	$589.1K	0.00%
Tudor Investment Corp Et Al	41,724	$554.1K	0.01%
Alpha DNA Investment Management LLC	37,640	$499.9K	0.27%
Two Sigma Advisers, LP	36,700	$487.4K	0.00%
Qube Research & Technologies Ltd	33,115	$439.8K	0.00%
Harbor Capital Advisors, Inc.	30,019	$399.0K	0.05%
Point72 Asset Management, L.P.	26,126	$347.0K	0.00%
Virtu Financial LLC	16,669	$221.0K	0.02%
Accredited Investors Inc.	15,045	$199.8K	0.01%
Susquehanna Fundamental Investments, LLC	14,370	$190.8K	0.01%
Cornercap Investment Counsel Inc	13,178	$175.0K	0.03%
Dark Forest Capital Management LP	11,799	$156.7K	0.03%
Corton Capital Inc.	11,753	$156.1K	0.06%
Deerfield Management Company, L.P. (Series C)	11,504	$152.8K	0.00%
Simplex Trading, LLC	9,215	$122.0K	0.00%
Fernwood Investment Management, LLC	6,000	$79.7K	0.02%
CIBC Private Wealth Group, LLC	2,223	$28.4K	0.00%
Pacer Advisors, Inc.	2,013	$26.7K	0.00%
KBC Group NV	1,750	$23.0K	0.00%
Macroview Investment Management LLC	587	$7.80K	0.01%
Riggs Asset Managment Co. Inc.	22	$293	0.00%
Abich Financial Wealth Management LLC	14	$186	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	11	$146	0.00%
Rothschild Investment LLC	10	$133	0.00%

Sold out (20)

Institutions that held Verve Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of VERV in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group	80,000	$1.12M
SG Americas Securities, LLC	50,802	$708.0K
ExodusPoint Capital Management, LP	24,036	$335.0K
HRT Financial LP	22,267	$310.0K
Caption Management, LLC	21,324	$297.3K
Seven Eight Capital, LP	20,562	$286.6K
Walleye Capital LLC	17,229	$240.2K
HighTower Advisors, LLC	15,698	$218.0K
Brevan Howard Capital Management LP	14,741	$205.5K
Sierra Summit Advisors LLC	12,709	$177.2K
Landscape Capital Management, L.L.C.	11,219	$156.4K
Algert Global LLC	10,452	$145.7K
Scientech Research LLC	10,289	$143.1K
Capstone Investment Advisors, LLC	10,173	$141.8K
PBCay One RSC Ltd	6,864	$95.7K
Itau Unibanco Holding S.A.	1,878	$26.2K
STRS Ohio	1,000	$13.0K
McIlrath & Eck, LLC	75	$1.05K
Bell Investment Advisors, Inc	42	$586
Cornerstone Planning Group LLC	2	$28

Not filed for Q1 2024 yet (1)

Institutions that held Verve Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VERV in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Wade G W & Inc	259,626	$3.62M